|Bid||15.42 x 0|
|Ask||15.44 x 0|
|Day's Range||15.33 - 16.02|
|52 Week Range||8.47 - 32.95|
|Beta (3Y Monthly)||3.96|
|PE Ratio (TTM)||21.84|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.29|
On Tuesday, Jim Cramer stated that Cronos Group and Aphria passed Canopy Growth. Canopy Growth has lost 15.3% of its stock value since its Q1 earnings.
Cresco Labs is set to declare its second-quarter results after markets close tomorrow. As of yesterday, its stock had risen 29.6% year-to-date.
Green Thumb is still trading in the positive territory this year. The company has fallen more than 25% since its first-quarter earnings.
Canopy Growth didn't impress investors with its earnings for the first quarter of 2020. The stock has fallen 12.4% since the company's earnings.
Despite Aurora Cannabis providing higher-than-expected guidance for fiscal 2019's fourth quarter early this year, its stock has fallen 25.6% this month.
Aurora Cannabis (ACB) announced that it's increasing its secured credit facility to 360 million Canadian dollars from $200 million Canadian dollars.
Altria (MO) stock has dipped roughly 5% so far in 2019, underperforming the broader market. MO stock is trading about 10% above its 52-week low price.
Piper Jaffray likes several U.S. cannabis stocks and one Canadian pot stock better than Aurora. Here are the analyst's picks -- and why they're good ones.
Canopy Growth (CGC) (WEED) is scheduled to announce its results for the first quarter of fiscal 2020 after the market closes on Wednesday.
Analysts expect Tilray to report revenues of $176.6 million and $358.3 million in 2019 and 2020, respectively. Tilray stock rose 8.4% before its earnings.
It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.